Lactobacillli expressing llama VHH fragments neutralise Lactococcus phages

por Hultberg, Anna, Tremblay, Denise M, de Haard, Hans, Verrips, Theo, Moineau, Sylvain, Hammarström, Lennart, Marcotte, Harold
Publicado 2007

VHH selected against the viral spike protein can protect mice against lethal rabies virus challenge

por Rosseels, Valérie, Vanlandschoot, Peter, Hultberg, Anna, Verrips, Theo, Saunders, Michael, de Haard, Hans, Francart, Aurélie, Kalai, Michael M, Van Gucht, Steven
Publicado 2011

Protective Effect of Different Anti-Rabies Virus VHH Constructs against Rabies Disease in Mice

por Terryn, Sanne, Francart, Aurélie, Lamoral, Sophie, Hultberg, Anna, Rommelaere, Heidi, Wittelsberger, Angela, Callewaert, Filip, Stohr, Thomas, Meerschaert, Kris, Ottevaere, Ingrid, Stortelers, Catelijne, Vanlandschoot, Peter, Kalai, Michael, Van Gucht, Steven
Publicado 2014

Structural Mimicry of Receptor Interaction by Antagonistic Interleukin-6 (IL-6) Antibodies

por Blanchetot, Christophe, De Jonge, Natalie, Desmyter, Aline, Ongenae, Nico, Hofman, Erik, Klarenbeek, Alex, Sadi, Ava, Hultberg, Anna, Kretz-Rommel, Anke, Spinelli, Silvia, Loris, Remy, Cambillau, Christian, de Haard, Hans
Publicado 2016

Dual anti-idiotypic purification of a novel, native-format biparatopic anti-MET antibody with improved in vitro and in vivo efficacy

por Godar, Marie, Morello, Virginia, Sadi, Ava, Hultberg, Anna, De Jonge, Natalie, Basilico, Cristina, Hanssens, Valérie, Saunders, Michael, Lambrecht, Bart N., El Khattabi, Mohamed, de Haard, Hans, Michieli, Paolo, Blanchetot, Christophe
Publicado 2016

S302: LONG-TERM SAFETY AND EFFICACY OF EFGARTIGIMOD IN PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA: INTERIM RESULTS OF THE ADVANCE+ STUDY

por Carpenedo, Monica, Broome, Catherine M, Mcdonald, Vickie, Miyakawa, Yoshitaka, Kuter, David, Al-Samkari, Hanny, Bussel, James, Matthijssens, Filip, Hultberg, Anna, Ayguasanosa Dachs, Jaume, De Beuf, Kristof, Rodeghiero, Francesco, Michel, Marc, Newland, Adrian
Publicado 2023

Results from a phase I/II trial of cusatuzumab combined with azacitidine in patients with newly diagnosed acute myeloid leukemia who are ineligible for intensive chemotherapy

por Pabst, Thomas, Vey, Norbert, Adès, Lionel, Bacher, Ulrike, Bargetzi, Mario, Fung, Samson, Gaidano, Gianluca, Gandini, Domenica, Hultberg, Anna, Johnson, Amy, Ma, Xuewen, Müller, Rouven, Nottage, Kerri, Papayannidis, Cristina, Recher, Christian, Riether, Carsten, Shah, Priya, Tryon, Jeffrey, Xiu, Liang, Ochsenbein, Adrian F.
Publicado 2023

Llama-Derived Single Domain Antibodies to Build Multivalent, Superpotent and Broadened Neutralizing Anti-Viral Molecules

por Hultberg, Anna, Temperton, Nigel J., Rosseels, Valérie, Koenders, Mireille, Gonzalez-Pajuelo, Maria, Schepens, Bert, Ibañez, Lorena Itatí, Vanlandschoot, Peter, Schillemans, Joris, Saunders, Michael, Weiss, Robin A., Saelens, Xavier, Melero, José A., Verrips, C. Theo, Van Gucht, Steven, de Haard, Hans J.
Publicado 2011

The NHance(®) Mutation-Equipped Anti-MET Antibody ARGX-111 Displays Increased Tissue Penetration and Anti-Tumor Activity in Advanced Cancer Patients

por Aftimos, Philippe, Rolfo, Christian, Rottey, Sylvie, Barthélémy, Philippe, Borg, Christophe, Park, Keunchil, Oh, Do-Youn, Kim, Sang-We, De Jonge, Natalie, Hanssens, Valérie, Zwanenpoel, Karen, Molthoff, Carla, Vugts, Daniëlle, Dreier, Torsten, Verheesen, Peter, van Dongen, Guus A.M.S., Jacobs, Julie, Van Rompaey, Luc, Hultberg, Anna, Michieli, Paolo, Pauwels, Patrick, Fung, Samson, Thibault, Alain, de Haard, Hans, Leupin, Nicolas, Awada, Ahmad
Publicado 2021